Stay updated with the latest growth-factor news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on growth-factor topics.
Stempeutics will have to meet certain regulatory milestones, he said, as the product would be made in India and sent to Japan In a first of sorts in stem cell therapy, India's Stempeutics has inked an "option licence agreement" with Japan's Medinet, a listed company focussed on regenerative medicine - to take the former's product used in treating chronic limb threatening ischemia (CLTI), to Japan. Japan is a tough regulatory market, BN Manohar, Stempeutics Chief Executive Officer told business ...Read More >
New Delhi, India - The quest for thicker, healthier hair has led many down a path of serums, supplements, and even surgical procedures. But a cutting-edge treatment utilizing microscopic "bubbles" called exosomes is emerging as a potential game-changer. Exosomes are tiny vesicles released by cells, acting as messengers carrying proteins and genetic material to other cells. This natural interaction system has sparked interest in the field of regenerative medicine, with exosome therapy showi ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.